Prodromal Symptoms in Patients with Bisphosphonate-Associated Atypical Fractures of the Femur

被引:0
作者
Mohammad Kharazmi
Karl Michaëlsson
Pär Hallberg
机构
[1] Central Hospital,Department of Oral and Maxillofacial Surgery
[2] Västerås,Section of Orthopaedics, Department of Surgical Sciences
[3] Uppsala University,Department of Medical Sciences
[4] Uppsala University,undefined
来源
Journal of Bone and Mineral Metabolism | 2015年 / 33卷
关键词
Atypical fracture; Bisphosphonate; Prodromal symptom; Adverse drug reaction; Osteoporosis;
D O I
暂无
中图分类号
学科分类号
摘要
Symptoms have been reported to precede bisphosphonate-associated atypical fractures (AFs) of the femoral shaft. We aimed to determine the frequency and clinical characteristics of such prodromal symptoms. We searched the Swedish national database of spontaneously reported adverse drug reactions for all cases of AF associated with bisphosphonates from January 2006 to March 2013. To confirm diagnostic accuracy and to characterize and determine the frequency of any prodromal symptoms we retrieved copies of medical journals and radiographs for patients who consented to participate in the study. The frequency of prodromal symptoms was compared with that of patients where information was based only on narratives from the adverse drug reaction case reports. A total of 45 reports of AF were identified. We were able to obtain medical records and x-rays for 21 cases and diagnostic accuracy was confirmed for all. Medical records revealed prodromal symptoms in 86 % (n = 18), most commonly pain in the ipsilateral thigh (14 out of 18 patients) preceding the fracture for weeks or longer. Awareness of such symptoms may facilitate early diagnosis and possible prevention of the AF.
引用
收藏
页码:516 / 522
页数:6
相关论文
共 50 条
  • [21] Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study
    Eisenstein, Neil
    Kasavkar, Ganesh
    Bhavsar, Dhruva
    Khan, Faisal Shehzaad
    Paskins, Zoe
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18 : 1 - 6
  • [22] Bilateral atypical femur fractures without bisphosphonate exposure
    Szolomayer, Lauren K.
    Ibe, Izuchukwu K.
    Lindskog, Dieter M.
    SKELETAL RADIOLOGY, 2017, 46 (02) : 241 - 247
  • [23] Atypical femur fractures: a complication of prolonged bisphosphonate therapy?
    Girgis, Christian M.
    Seibel, Markus J.
    MEDICAL JOURNAL OF AUSTRALIA, 2010, 193 (04) : 196 - 198
  • [24] Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study
    Neil Eisenstein
    Ganesh Kasavkar
    Dhruva Bhavsar
    Faisal Shehzaad Khan
    Zoe Paskins
    BMC Musculoskeletal Disorders, 18
  • [25] A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture
    Kharazmi, Mohammad
    Michaelsson, Karl
    Schilcher, Jorg
    Eriksson, Niclas
    Melhus, Hakan
    Wadelius, Mia
    Hallberg, Par
    CALCIFIED TISSUE INTERNATIONAL, 2019, 105 (01) : 51 - 67
  • [26] Atypical fractures of the femur and bisphosphonate therapy A systematic review of case/case series studies
    Giusti, Andrea
    Hamdy, Neveen A. T.
    Papapoulos, Socrates E.
    BONE, 2010, 47 (02) : 169 - 180
  • [27] Current concepts in the management of bisphosphonate associated atypical femoral fractures
    Rudran, Branavan
    Super, Jonathan
    Jandoo, Rajan
    Babu, Victor
    Nathan, Soosai
    Ibrahim, Edward
    Wiik, Anatole Vilhelm
    WORLD JOURNAL OF ORTHOPEDICS, 2021, 12 (09): : 660 - 671
  • [28] Risk factors for atypical forearm fractures associated with bisphosphonate usage
    Cha, Soo Min
    Shin, Hyun Dae
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2021, 52 (06): : 1423 - 1428
  • [29] Bisphosphonate-associated adverse events
    Papapetrou, Peter D.
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2009, 8 (02): : 96 - 110
  • [30] Bisphosphonate-associated adverse events
    Peter D. Papapetrou
    Hormones, 2009, 8 : 96 - 110